Trinity Hunt Partners Launches Acuvance Healthcare Advisory Platform Amid Industry Transformation
Private equity firm Trinity Hunt Partners has branded its growing healthcare advisory platform as Acuvance, creating a national firm to help healthcare organizations navigate unprecedented regulatory complexity and operational challenges.
Trinity Hunt Partners, a growth-oriented private equity firm, has announced the branding of its healthcare advisory platform as Acuvance, marking a significant consolidation in the healthcare consulting sector. The newly branded platform unites leading firms on a national basis, offering strategic, operational, financial, clinical, technology, and compliance expertise to help healthcare organizations adapt, perform, and grow during a period of unprecedented industry transformation.
The creation of Acuvance represents a strategic response to the healthcare industry's increasing regulatory complexity and operational challenges that demand sophisticated advisory solutions. According to Josh Nazarian, CEO of Acuvance, the platform's mission is to help healthcare organizations succeed amid complexity by providing sharp insight, deep expertise, pragmatic execution, and a relentless focus on outcomes. The Acuvance brand embodies the vision to build a national leader capable of addressing the full spectrum of financial, operational, and clinical healthcare advisory needs.
Acuvance was initially formed through Trinity Hunt's foundational investment in Coker in December 2023, and the platform has since executed five strategic acquisitions. The firm is actively seeking additional acquisition opportunities to bolster its presence as a high-impact, scalable healthcare advisory firm capable of serving a wider range of client needs, including clinical advisory, revenue cycle transformation, and performance transformation. For more information about the platform's services, visit https://www.acuvance.com.
The platform's growth strategy remains focused on executing strategic acquisitions, making targeted investments in talent and technology, and accelerating organic growth. As Acuvance continues to diversify beyond its provider-focused foundation, the company is establishing new practice area pillars that will broaden its market reach and strategic service capabilities. This expansion comes at a critical time when healthcare organizations nationwide require comprehensive support to navigate evolving regulatory requirements and operational pressures.
Joining CEO Josh Nazarian on the platform leadership team are Alex Graves as Chief Financial Officer, John Reiboldt as Chief Development Officer, Michelle Liro as Senior VP of Marketing, Ayanna Chambliss as Senior VP of Talent Success, and Greg Alperstein as VP of Integrations. This experienced leadership team combines deep healthcare expertise with strategic vision to position Acuvance as a differentiated leader in the healthcare advisory space.
John Oakes, Partner at Trinity Hunt Partners, emphasized that the Acuvance platform builds on the exceptional client service and relationships that Coker has demonstrated for over three decades. The combination of Acuvance's leadership capabilities and strategic vision positions the platform well to become a market leader. Trinity Hunt Partners, which manages over $2 billion of assets and was ranked tenth amongst all firms worldwide on HEC-Dow Jones' most recent Top Small-Cap Buyout Firms List, continues to seek additional information through its website at https://www.trinityhunt.com.
Acuvance is actively seeking additional partnerships with like-minded healthcare advisory firms across the United States, signaling continued consolidation in the healthcare consulting industry. This development reflects broader trends in private equity investment in healthcare services, particularly as organizations seek scalable solutions to address complex regulatory environments and operational challenges. The platform's national approach and comprehensive service offerings position it to capture significant market share as healthcare providers increasingly turn to specialized advisory firms for guidance.